Elon xAI’s to Unleash Upgraded Grok-1.5 ChatBot This Week

Good Morning, Team!

Happy April Fools Day! Today, anything goes. But don't worry, amidst all the jokes, The Team promises to give you truths when it comes to the world of AI, even though a lot of these innovations are hard to believe!

TRACK HIGHLIGHTS
Article Takeaways

• Grok-1.5 To Be Released This Week
• AI Might Be More Thorough Than Doctors
• Tesla Hits a Rough Patch
• AI’s Breakthrough Drug Battle
• Local CoPilot Plans Discussed by Intel, Microsoft

MARKET PITSTOP
A Quick Look at the Market

The Stock Market was closed on Good Friday but ended on a high note. Here is a quick recap on performance to close the month of March.

Stock Market: Wall Street coasted to its latest winning month and quarter by rising to more records. The S&P 500 rose 0.1% Thursday, adding to its all-time high set the day before. It roared 10.2% in the first three months of the year as the market continues a nearly unstoppable run that began last October. The Dow Jones Industrial Average rose 0.1%, and the Nasdaq composite slipped 0.1%.

Crypto: Bitcoin rebounded over the last 7 days crossing $70,000 once again and currently hovering over that figure while Ethereum followed suit, both hovering near a 7% gain over the last week.

LAP 1 - Featured Story
Elon xAI’s to Unleash Upgraded Grok-1.5 ChatBot This Week

• Musk says xAI's chatbot Grok-1.5 will be available to the public this week.
• Grok-1.5 boasts improved capabilities and context length of 128,000 tokens.
• Grok-2 is confirmed to be in development, expected to surpass current AI metrics.
• Musk's xAI competes with OpenAI in the rapidly growing AI chatbot market. 

Billionaire Elon Musk announced that xAI's chatbot Grok-1.5 will soon be available to the public as an open-source tool, marking its entry into the competitive AI chatbot market. The latest version boasts improved reasoning capabilities and a context length of 128,000 tokens, promising enhanced performance for users. Designed to outperform previous models and competitors, it excels in coding tasks, offering notable advancements. Its specialized focus on programming ensures solutions are delivered with enhanced accuracy and efficiency, catering to the needs of coders and developers.

Additionally, Musk hinted at the development of Grok 2, expected to surpass current AI standards, while also revealing ongoing legal disputes with OpenAI over the open-sourcing of its ChatGPT model.

Elon Musk's xAI, launched last July to compete with OpenAI, introduced the initial Grok version in November, initially restricted to premium users. However, Musk later announced plans to open-source Grok, aiming to democratize access to AI technology. The AI chatbot landscape has intensified with OpenAI's ChatGPT and Google's subsequent entries, Bard and Gemini, leading to controversies over accuracy and functionality, as highlighted by Musk's recent criticism of Google's AI practices.

LAP 2
AI vs. MD: ChatGPT's Empathetic Edge in Healthcare Conversations

• AI in healthcare might be more empathetic than doctors, in a recent study.
• Study found ChatGPT's medical responses are more detailed and thorough.
• Collaboration between AI and physicians might enhance patient care, but accuracy still proves to be the most crucial factor.

A study done by Harvard Medical School suggests that AI, specifically ChatGPT, provides answers to medical questions with greater empathy and quality than human doctors has stirred both interest and skepticism. According to the research, ChatGPT scored significantly higher in both quality and empathy in answering patient questions compared to real doctors. This finding prompts a reconsideration of how AI can complement healthcare, especially in terms of enhancing communication and patient support.

However, the study also highlighted important limitations, such as the absence of accuracy assessment in the AI's responses and the potential bias due to the evaluators possibly recognizing which answers were AI-generated due to their length. These findings underscore the potential for AI to serve as a collaborative tool in healthcare, aiding physicians rather than replacing them. It suggests a future where AI enhances the healthcare experience by ensuring questions are met with prompt, empathetic responses while maintaining the necessity for human oversight to ensure accuracy and maintain trust.

BRAIN TEASER
What has cities, but no houses; forests, but no trees; and water, but no fish? (If you want the easy way out, the answer is at the end!)

WALLSTREET PITSTOP
Tesla Hits a Rough Patch: First Quarter Challenges Signal a Stormy Start to 2024

• Tesla faces potential first year-over-year sales decline since 2020.
• Early estimates suggest underperformance in the US and China, Tesla's largest markets.
• Investor and analyst delivery forecasts diverge, impacting stock expectations.
• Europe shows growth but may not offset declines elsewhere.

Tesla is navigating turbulent waters in Q1, with early indicators suggesting the electric vehicle giant might report its first year-over-year sales dip since the 2020 pandemic lockdowns. Despite aggressive pricing strategies and enhanced subsidies, Tesla's performance in its key markets, the US and China, shows a decline, casting shadows over its previously unstoppable growth narrative. The situation is further complicated by production setbacks, including an update to the Model 3 line. Analysts are recalibrating their expectations, with even bullish voices dialing back their delivery forecasts.

LAP 3
AI's Breakthrough Battle Against Superbugs: SyntheMol's Revolutionary Drug Designs

• AI model SyntheMol designs drugs to fight antibiotic-resistant bacteria.
• SyntheMol bridges computational design with practical lab synthesis, overcoming previous AI limitations.
• Generative AI explores uncharted chemical spaces, offering new paths for antibiotic development.

Amid the global health crisis of antibiotic resistance, which results in nearly 5 million deaths annually, innovative solutions are crucial. Researchers from Stanford Medicine and McMaster University have taken a significant step forward by employing generative artificial intelligence to create new drugs capable of combating resistant strains of bacteria.

Their AI model, SyntheMol, has successfully designed and provided recipes for six new drugs targeting Acinetobacter baumannii, a major contributor to deaths from antibiotic resistance. This breakthrough is particularly exciting as it leverages AI to venture into previously unexplored chemical spaces, potentially revolutionizing how we discover and develop antibiotics. By training SyntheMol with a vast library of molecular components and validated chemical reactions, the team not only discovered new compounds but also devised practical methods for their synthesis.

FUN FACT STOP
Australia is wider than the moon. The moon sits at 3400km in diameter, while Australia’s diameter from east to west is almost 4000km.

LAP 4
Intel and Microsoft Explore Running Copilot Locally on PCs

• Intel's new program boosts AI features locally rather than on the Cloud.
• Microsoft targets 2024 for "AI PC" era.
• Next-gen PCs to require powerful NPUs.

Microsoft has heralded 2024 as the year of the "AI PC," promising new hardware features like a built-in neural processing unit (NPU) and the Copilot key for keyboards. The specifics of these AI PCs and their benefits to users have been relatively scant, until now. Intel's announcement of a new AI PC developer program sheds some light, suggesting that AI PCs will empower local processing of AI features, enhancing user privacy and responsiveness. Microsoft is expected to mandate NPUs capable of 40 trillion operations per second (TOPS) in next-gen AI PCs, potentially leading to a shift towards Qualcomm's Snapdragon X processors over Intel chips in Surface tablets.

Additionally, Intel is facilitating AI PC development with kits centered around Asus' NUC Pro 14 mini PC, equipped with Meteor Lake silicon and an integrated NPU, offering a glimpse into the future of AI-infused computing.

FINAL LAP - FINANCE & THE STOCK MARKET
Market Highlights: Bitcoin ETFs Rebound, Yen Declines, Interest Rate Predictions, and Gold Records

• After a week of outflows, U.S. spot bitcoin ETFs rebounded with $859.7 million in positive inflows from March 25 to March 28.

• Japanese Finance Minister Shunichi Suzuki said on Monday there were some speculative moves in the currency market that did not reflect economic fundamentals, repeating his warning against excessive yen declines.

• Real estate mogul Barbara Corcoran predicts interest rate cut could create a surge in home prices.

• Gold Rises to Record as Cooling US Inflation Aids Rate-Cut Bets.

BRAIN TEASER ANSWER

A Map!

THE RACE CONCLUDES
Thank You for Joining us on the AI Race! 🏁 

We want to THANK YOU for joining us on this exciting journey into the world of AI! Our mission is simple - to keep those who feel left behind in the AI curve up to date.

Your subscription marks the beginning of a collaborative exploration into the boundless possibilities of Artificial Intelligence.

Warm regards,

AI Pitstop Team